Abiopharma

🔍 MONTGOMERY PHILIP (Executive)

Company: LITHIUM AMERICAS CORP. (LAC)

Report Date: 2026-04-13

Detailed Transactions and Holdings:

• Acquired 7,919 shares of Deferred Share Units ("DSUs") (Derivative)
  Date: 2026-04-13 | Code: A | equity_swap_involved: false | shares_owned_after: 73,374.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each DSU represents the right to receive one common share of the Issuer. The underlying common shares will not be issued to the Reporting Person, and the Reporting Person shall not have any voting or dispositive rights with respect to the underlying common shares, until termination of the Reporting Person's employment or services as a director of the Issuer. Grants to U.S. eligible participants will be settled with no further action by the Reporting Person on the date that is 6 months following the Reporting Person's termination date. Grants to non-U.S. eligible participants will be settled with no further action by the Reporting Person on the 20th business day following the Reporting Person's termination date.